3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Carcinoma, Renal Cell
4
Carcinoma, Hepatocellular
4
Melanoma
2
Endometrial Neoplasms
2
von Hippel-Lindau Disease
1
Triple Negative Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Ovarian Neoplasms
1
Neoplasms
1
Hematologic Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Clear-cell metastatic renal cell carcinoma
1
Cirrhosis, Familial, with Pulmonary Hypertension
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Adenoid Cystic
1
Brain Neoplasms
1
Bone Neoplasms
1
Advanced Malignancies
1
Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
1
Adenocarcinoma
1
Interventions
Bevacizumab
12
olaparib
11
Paclitaxel
11
Carboplatin
11
liposomal doxorubicin
7
Specimen Handling
7
Magnetic Resonance Spectroscopy
6
Taxes
5
Immunoglobulin G
5
Disulfides
5
mirvetuximab soravtansine
4
cediranib
4
Topotecan
4
Gemcitabine
4
Biopsy
4
pembrolizumab
3
Oxaliplatin
2
Doxorubicin
2
1-dodecylpyridoxal
2
vistusertib
1
tremelimumab
1
trastuzumab deruxtecan
1
sotorasib
1
sarilumab
1
palbociclib
1
niraparib
1
nilotinib
1
neratinib
1
irinotecan sucrosofate
1
ipatasertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
lenvatinib
×
30 days
×
Clear all
No trials found.